Predictors of post-partum damage accrual in systemic lupus erythematosus:: data from LUMINA, a multiethnic US cohort (XXXVIII)

被引:29
作者
Andrade, R. M.
McGwin, G., Jr.
Alarcon, G. S.
Sanchez, M. L.
Bertoli, A. M.
Fernandez, M.
Fessler, B. J.
Apte, M.
Arango, A. M.
Bastian, H. M.
Vila, L. M.
Reveille, J. D.
机构
[1] Univ Alabama Birmingham, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL USA
[2] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Dept Surg, Sect Trauma Burns & Crit Care, Sch Med, Birmingham, AL 35294 USA
[4] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL 35294 USA
[5] Univ Puerto Rico, Div Rheumatol, Dept Internal Med, San Juan, PR 00936 USA
[6] Univ Texas, Hlth Sci Ctr, Div Rheumatol, Dept Med, Houston, TX USA
关键词
pregnancy; outcome; SLE; damage; predictors;
D O I
10.1093/rheumatology/kel222
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To determine the impact of pregnancy on systemic lupus erythematosus (SLE) outcome. Methods. SLE patients, age >= 16 yrs, disease duration <= 5 yrs at enrolment in LUMINA, a multiethnic cohort (Hispanics, African-Americans and Caucasians), were studied. The first pregnancy after SLE diagnosis was examined. A good pregnancy outcome was a full-term delivery; an adverse outcome was a miscarriage, abortion, premature birth or stillbirth. Dependent variables were disease activity (Systemic Lupus Activity Measure-Revised, SLAM-R) and damage accrual [Systemic Lupus International Collaborating Clinics (SLICC) Damage Index, SDI]. Differences in these variables between the visit immediately prior to, and the first visit after, pregnancy and their relationship with pregnancy outcome were examined. Damage accrual due to pregnancy exposure was examined by a case-crossover design. Results. Sixty-three SLE women from all ethnic groups were included. The mean (s.d.) age and disease duration at pregnancy outcome were 27.6 (6.5) yrs and 18.3 (22.5) months, respectively. Adverse pregnancy outcomes occurred in 76.2% women. The SLAM-R and SDI scores were statistically different after pregnancy (P = 0.050 and P < 0.001, respectively); the SDI score was independent of pregnancy outcome but strongly associated with pregnancy duration (P = 0.006), disease activity (P = 0.001), damage prior to pregnancy (P < 0.001) and total disease duration (P = 0.039) by multivariable analyses. Exposure to pregnancy itself did not impact on damage accrual in the case-crossover analyses of 142 patients (17 pregnancy exposures) (OR = 1.25; 95% CI 0.336-4.655; P = 0.480). Conclusions. Pregnancy duration, total disease duration, disease activity and damage immediately prior to pregnancy decisively impact on damage accrual after pregnancy in patients with SLE.
引用
收藏
页码:1380 / 1384
页数:5
相关论文
共 30 条
  • [21] Lupus pregnancy
    Lockshin, MD
    Sammaritano, LR
    [J]. AUTOIMMUNITY, 2003, 36 (01) : 33 - 40
  • [22] Should we use a case-crossover design?
    Maclure, M
    Mittleman, MA
    [J]. ANNUAL REVIEW OF PUBLIC HEALTH, 2000, 21 : 193 - 221
  • [23] MINTZ G, 1986, J RHEUMATOL, V13, P732
  • [24] Prospective study of systemic lupus erythematosus pregnancies
    Petri, M
    [J]. LUPUS, 2004, 13 (09) : 688 - 689
  • [25] RAMIREZ R, 2002, CURRENT POPULATION R
  • [26] RuizIrastorza G, 1996, BRIT J RHEUMATOL, V35, P133
  • [27] Do present damage and health perception in patients with systemic lupus erythematosus predict extent of future damage? a prospective study
    Stoll, T
    Sutcliffe, N
    Klaghofer, R
    Isenberg, DA
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2000, 59 (10) : 832 - 835
  • [28] LUPUS AND PREGNANCY STUDIES
    UROWITZ, MB
    GLADMAN, DD
    FAREWELL, VT
    STEWART, J
    MCDONALD, J
    [J]. ARTHRITIS AND RHEUMATISM, 1993, 36 (10): : 1392 - 1397
  • [29] Hormonal regulation of tumor necrosis factor-α, interleukin-12 and interleukin-10 production by activated macrophages -: A disease-modifying mechanism in rheumatoid arthritis and systemic lupus erythematosus?
    Wilder, RL
    Elenkov, IJ
    [J]. NEUROENDOCRINE IMMUNE BASIS OF THE RHEUMATIC DISEASES, 1999, 876 : 14 - 31
  • [30] Hormones, pregnancy, and autoimmune diseases
    Wilder, RL
    [J]. NEUROIMMUNOMODULATION: MOLECULAR ASPECTS, INTEGRATIVE SYSTEMS, AND CLINICAL ADVANCES, 1998, 840 : 45 - 50